Breast Cancer Index

After completing five years of hormone therapy for breast cancer, a critical question arises: "What's next?" This video introduces the Breast Cancer Index (BCI), a specialized genomic test designed to help answer that question. It analyzes your original tumor's biology to predict the risk of the cancer returning late (after five years) and, crucially, identifies who is most likely to benefit from continuing hormone therapy.

In this video, we cover:

• The Five-Year Crossroads: Discussing the important decision patients with HR+ breast cancer face about extending their treatment.

• Two Answers from One Test: The BCI provides two key pieces of information:

  1. Your individual risk of late recurrence.

  2. Whether you are likely to benefit from another five years of hormone therapy.

• How the Test Works: A simple explanation of how BCI analyzes a small sample of the tissue removed during your original surgery—no new procedure is needed.

• Understanding Your BCI Results: Learn how the test provides clear information to help you and your doctor understand your long-term outlook.